Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart sensors track hidden heart risks in duchenne MD

NCT ID NCT06124196

First seen May 23, 2026 · Last updated Jun 20, 2026 · Updated 3 times

Summary

This study uses three wearable devices—a continuous glucose monitor, a heart monitor, and an activity tracker—to see if high blood sugar is linked to heart problems in people with Duchenne muscular dystrophy. Researchers will compare 80 participants with and without DMD. The goal is to understand risk factors for heart failure, the leading cause of death in DMD, without requiring frequent clinic visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could point to new ways to screen for or delay heart failure in Duchenne muscular dystrophy.

What could go wrong

This is an observational study, not a treatment trial. It is small (80 people) and early, so findings may not lead to immediate changes in care.

Conditions

The condition(s) this trial relates to.

cardiomyopathy Duchenne muscular dystrophy heart failure hyperglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.